Laia Paré

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Francesco Schettini, Núria Chic, Fara Brasó‐Maristany et al. · npj Breast Cancer · 2021 · 655 citations · Full text

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Aleix Prat, Alejandro Navarro, Laia Paré et al. · Cancer Research · 2017 · 468 citations

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer

Deena M.A. Gendoo, Natchar Ratanasirigulchai, Markus Schröder et al. · Bioinformatics · 2015 · 388 citations · Full text

HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial

Antonio Llombart‐Cussac, Javier Cortés, Laia Paré et al. · The Lancet Oncology · 2017 · 329 citations

Breast Oncology, Medicine, Pathology +8

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer

Juan Miguel Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván et al. · Cancer Research · 2017 · 239 citations · Full text